BEECHAM GROUP PLC - Profile & Financials

Accounts Submitted 22 May 2025

Confirmation Statement Submitted 4 Aug 2025

Net assets £644.71M £24.16M 2024 year on year

Total assets £664.05M £32.45M 2024 year on year

Total Liabilities £19.34M £8.28M 2024 year on year

Charges None No charges registered

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

79 New Oxford Street London WC1A 1DG United Kingdom

Credit Report

Discover BEECHAM GROUP PLC's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2024

Type Total Exemption Full

Next accounts 31 December 2025

Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

N/A

Net Assets

£644.71M

Increased by £24.16M (+4%)

Total Liabilities

£19.34M

Increased by £8.28M (+75%)

Turnover

N/A

Employees

N/A

Debt Ratio

Increased by 1 (+50%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 Dec Year End	2023 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

4 active 21 resigned

Show resigned officers

						Status
Ciara Martha Lynch	Director	Irish	England	57	2 Mar 2020	Active
Edinburgh Pharmaceutical Industries Limited	Corporate-director	United Kingdom	Unknown	—	2 Mar 2001	Active
Glaxo Group Limited	Corporate-director	United Kingdom	Unknown	—	2 Mar 2001	Active
Victoria Anne Whyte	Secretary	British	Unknown	—	29 Oct 2004	Active

Shareholders

Shareholders (6)


Smithkline Beecham Limited	50.0%	763,242,055	Ordinary B	16 Aug 2024
Smithkline Beecham Limited	50.0%	763,242,055	Ordinary A	16 Aug 2024
Smith Kline & French Laboratories Limited	0.0%	0	Ordinary A	16 Aug 2024

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Smithkline Beecham Limited

United Kingdom

Active

Notified 4 Jun 2024

Nature of Control

Ownership Of Shares 75 To 100 Percent
Voting Rights 75 To 100 Percent
Right To Appoint And Remove Directors

Smithkline & French Laboratories Limited

United Kingdom

Active

Notified 6 Apr 2016

Nature of Control

Ownership Of Shares 75 To 100 Percent
Voting Rights 75 To 100 Percent
Right To Appoint And Remove Directors

See All Controllers

Group Structure

SMITH KLINE & FRENCH LABORATORIES LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

SMITHKLINE BEECHAM LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GLAXOSMITHKLINE FINANCE PLC united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GLAXOSMITHKLINE HOLDINGS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GSK PLC united kingdom

BEECHAM GROUP PLC Current Company

Charges

No charges registered

Documents

Company Filings

Date	Category	Description	Document
4 Aug 2025	Confirmation Statement	Confirmation statement made on 2025-08-04 with no updates	View(3 pages)
4 Jul 2025	Officers	Change to director Mrs Ciara Martha Lynch on 2025-06-27	View(2 pages)
22 May 2025	Accounts	Annual accounts made up to 2024-12-31	View(19 pages)
23 Sept 2024	Officers	Change Person Secretary Company With Change Date	View(1 page)
17 Sept 2024	Officers	Change to director Mrs Ciara Martha Lynch on 2024-09-11	View(2 pages)